Abstract
Background
Evidence suggests perinatal environments influence the risk of developing insulin resistance.
Objective
The present study was aimed at determining the effects of intrauterine exposure to germinated brown rice (GBR) and GBR-derived gamma (γ) aminobutyric acid (GABA) extract on epigenetically mediated high fat diet–induced insulin resistance.
Design
Pregnant Sprague Dawley rats were fed high-fat diet (HFD), HFD+GBR, or HFD+GABA throughout pregnancy until 4 weeks postdelivery. The pups were weighed weekly and maintained on normal pellet until 8 weeks postdelivery. After sacrifice, biochemical markers of obesity and insulin resistance including oral glucose tolerance test, adiponectin, leptin, and retinol binding protein-4 (RBP4) were measured. Hepatic gene expression changes and the global methylation and histone acetylation levels were also evaluated.
Results
Detailed analyses revealed that mothers given GBR and GABA extract, and their offspring had increased adiponectin levels and reduced insulin, homeostasis model assessment of insulin resistance, leptin, oxidative stress, and RBP4 levels, while their hepatic mRNA levels of GLUT2 and IPF1 were increased. Furthermore, GBR and GABA extract lowered global DNA methylation levels and modulated H3 and H4 acetylation levels.
Conclusions
These results showed that intrauterine exposure to GBR-influenced metabolic outcomes in offspring of rats with underlying epigenetic changes and transcriptional implications that led to improved glucose homeostasis.
Keywords: epigenetics, germinated rice bran, gamma amino-butyric acid, insulin resistance
Nutrition plays a vital role in many facets of health, and dietary imbalances are major determinants of chronic diseases such as insulin resistance. Also, chronic diet-related diseases are responsible for more than half of all deaths worldwide and have a great impact on national economies (1). In many industrialized countries today, excess caloric intake is a major determinant of insulin resistance (2). Thus, adequate nutrition is particularly crucial during critical periods in early life (pre and postnatal) because it plays an important role in adult onset of chronic disease (3, 4). Interventions during this critical developmental window might provide opportunities to decrease the burden of metabolic diseases such as insulin resistance later in life (5). It has been well documented that insulin resistance, which underlies the symptomatology in type 2 diabetes mellitus is the key feature of the metabolic syndrome (6).
Diabetes mellitus affects a great majority of people globally, and by 2030 the burden of the disease is estimated to reach 552 million people. The International Diabetes Federation estimated that diabetes mellitus accounts for 5–10% of the total health-care budget in many countries (7). In the absence of a complete cure for this disease, current treatment options seek to keep metabolic derangements under tight control, through one or a combination of lifestyle modifications, medications, and diet (8). Many of the drugs currently in use are expensive, and side effects are of serious concern (9). In this regard, natural products have received heightened interest because of their perceived cost-effectiveness and fewer side effects.
Cereals such as rice and wheat are important foods for their rich carbohydrate content (10). Germination of such cereals is an economical processing technology, with numerous advantages and health benefits (11, 12). Recently, germinated brown rice (GBR) has been seen as one of the most interesting germinated cereal products and it has garnered a great deal of attention, especially in Asian countries (13). During the process of germination the chemical compositions of the rice change drastically because the biochemical activity produces essential compounds and energy for the formation of the seedling. Germination is therefore considered an important way to improve bioactive compounds and health benefits of rice grains, as reported severally (11–13). Among the various bioactive compounds potentiated during germination of rice grains, we have demonstrated that γ-aminobutyric acid (GABA) contributes significantly toward the overall bioactivity of GBR (13). However, the fact that GABA does not explain the overall effects of GBR suggests that multiple bioactive compounds produce the effects of GBR through synergy. In view of the improved glucose and cholesterol homeostasis and other health outcomes observed when GBR is consumed (11–13), we hypothesized that it may have similar effects on offspring of rats when it is consumed during pregnancy. Furthermore, we have demonstrated that in utero exposure to brown rice can protect offspring against high fat diet–induced insulin resistance (14). Thus, in the present study, the effects of GBR and its GABA-rich extract were evaluated for their effects on high fat diet–induced epigenetic modifications leading up to insulin resistance in offspring of rats exposed to a high fat–diet in pregnancy.
Methods
Chemicals, enzyme-linked immunosorbent assays, and epigenetic kits
All solvents were of analytical grade from Merck (Darmstadt, Germany). Biotechnology grade water was obtained from Sigma-Aldrich (St Loius, MO, USA). Rat adiponectin (Catalog No EZRADP-62K) and insulin (Catalog No EZRMI-13K) enzyme-linked immunosorbent assay (ELISA) kits were procured from Millipore Corporation (Billerica, USA). Rat retinol binding protein-4 dual ELISA kit (Catalog No AG-45A-0012YEK-K101) was obtained from Adipogen International (Liestal, Switzerland). Rat 8-iso prostaglandin (Catalog No E-EL-R2488) and rat leptin ELISA kit (Catalog No E-EL-R0582) were purchased from Elabscience Biotechnology Co., Ltd (Wuhan, P.R.C) and rat interleukin 6 (IL-6) (Catalog No CSB-E04640r) ELISA kit was purchased from Cusabio (Wuhan, P.R.C). MethylFlash™ Methylated DNA Quantification Kit (Fluorometric) (Catalog No P-1035), Epiquick™ Total Histone Extraction Kit (Catalog No OP-0006), Epiquick™ Total Histone H3 Quantification Kit (Fluorometric) (Catalog No P-3063), Epiquick™ Total Histone H4 Quantification Kit (Fluorometric) (Catalog No P-3073), Epiquick™ Total Histone H3 Acetylation Detection Fast Kit (Fluorometric) (Catalog No P-4031), and Epiquick™ Total Histone H4 Acetylation Detection Fast Kit (Fluorometric) (Catalog No P-4033) were obtained from EPIGENETIK (Brooklyn, NY, USA).
Germination of brown rice and extraction of GABA
Brown rice (MR220 variety) was obtained from PadiBeras Nasional Berhad (Selangor, Malaysia) and germinated as described previously (15). Briefly, 500 g brown rice was washed twice using tap water, after which sodium hypochlorite was added at a ratio of 1:2 (w/v) and left to soak for 30 min. It was then drained and rinsed with distilled water and subsequently soaked in hydrogen peroxide (H2O2) 1:2 (w/v) prior to incubation for 6 h at 37°C. Then, H2O2 was drained and the rice incubated once again in a closed plastic container for 18 h at 37°C and later oven-dried at 50°C until moisture content of 8–11% was achieved. It was then ground with a stainless steel grinder (Waring Commercial, Torrington, CT, USA) and used in preparing the rat pellets.
The extraction of GABA from GBR was done according to (15). Ethanol (400 ml; 70%) was mixed with approximately 100 g of ground GBR and sonicated for 30 min. It was then centrifuged for 20 min at 34,800 g. Whatman Grade 1 filter paper with the aid of a glass funnel was used to filter the supernatant and the extraction process repeated twice for a total of three extractions. The filtered supernatants were pooled and dried using a rotary evaporator (Rotavapor® R-210, BUCHI, Flawil, Switzerland).
Experimental design
All animal experiments were implemented in accordance with the guidelines for the use of animals as approved by the Animal Care and Use Committee, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (approval number UPM/FPSK/PADS/BR-UUH/00360). Fifteen female Sprague Dawley rats raised on regular chow diet by the breeder were fed regular chow ad libitum and free water access during the acclimatization week. They were then grouped (n=3) into high-fat diet (HFD), regular chow (N), 50% GBR (GBR), high-dose GABA extract (GEHD), and low-dose GABA extract (GELD) (Table 1). Male Sprague Dawley rats that had been fed with regular chow were mated with the female rats, and the female rats were maintained on the above diets during pregnancy and lactation. Food intake was set at 30 kcal/100 g body weight/day for all the groups. After delivery, male offspring were chosen for follow-up on the effects of the perinatal interventions on insulin resistance markers. At week 4, the male offspring (n=6 per group) were weaned and maintained on regular chow for 4 weeks. Weekly weights of the offspring were taken for a duration of 8 weeks.
Table 1.
Groups | High-fat dieta (%) | Others |
---|---|---|
Normal | 0 | 100% normal rat pellet |
High-fat diet | 50 | 50% normal rat pellet |
Germinated brown rice | 50 | 50% germinated brown rice |
Low-dose GABA extract | 100 | 100 mg/kg/day GABA extract |
High-dose GABA extract | 100 | 200 mg/kg/day GABA extract |
High-fat diet was formulated as previously reported by Imam (16).
Oral glucose tolerance test
In order to appraise the effects of the different treatments in the mothers and offspring on systemic glucose homeostasis, an oral glucose tolerance test was performed. Rats were initially fasted overnight prior to oral glucose tolerance test via intragastric gavage using a glucose solution (2 g/kg body weight). This was done after weaning in the mothers and at 8 weeks postdelivery for the offspring. Blood samples were taken from the tail vein at 0, 30, 60, 90, and 120 min using a glucometer.
Homeostasis model assessment of insulin resistance (HOMA-IR)
HOMA-IR values were calculated as described by (17)
Insulin, adiponectin, leptin, RBP 4, 8-iso prostaglandin and interleukin 6
Serum levels of these markers were determined using the respective ELISA kits according to the manufacturer's instructions. Absorbance were read on a microplate reader at the recommended wavelengths and the results calculated from the respective standard curves; Insulin (y=0.153x+0.3572, R2=0.9911) ng/ml, Adiponectin (y=0.0026x+0.1455, R2=0.9985) ng/ml, Leptin (y=.2215x+0.0286, R2=0.9982) ng/ml, RBP 4 (y=0.1041x+0.2977, R2=0.9875) ng/ml, 8-iso prostaglandin (y=0.0024x+0.3167, R2=0.9781) pg/ml, and interleukin 6 (y=0.081x+0.2641, R2=0.9804) pg/ml.
DNA/RNA isolation
DNA and RNA were extracted from liver tissues using the ZR-Duet™ DNA/RNA MiniPrep (Zymo Research, Irvine, CA, USA) according to the manufacturer's instructions. Then, quality and quantity assessments of the extracted samples were done using Implem NanoPhotometer® (Munchen, Germany) prior to storage at −80°C.
Gene expression analysis
The primers were designed on the NCBI website and purchased from Integrated DNA Technologies (Singapore), while the internal control (KanR) was supplied by Beckman Coulter (Miami, FL, USA) (Table 2). Forward and reverse primer stocks were diluted to a concentration of 200 nm and 500 nm, respectively, in nuclease free water. Reverse transcription of each sample RNA (50 ng) along with multiplex universal reverse primers to complimentary DNA (cDNA) was done using an XP Thermal cycler (BIOER Technology, Germany) for 1 min at 48°C, 5 min at 37°C, 60 min at 42°C, 5 min at 95°C, and a final hold at 4°C as stated in the GenomeLab™ Start Kit (Beckman Coulter, Miami, FL, USA). A reaction mixture containing cDNA product (9.3 µl), 5 X PCR Master Mix buffer (4 µl), forward universal primer set mix (200 nM, 2 µl, MgCl2) (25 mM, 4 µl) and Thermo Start Taq DNA polymerase (0.7 µl) (Thermo Fisher Scientific) was then used to run polymerase chain reaction (PCR) in an XP Thermal Cycler (BIOER Technology, Germany). Amplification was done at initial denaturation temperature of 95°C for 10 min followed by 35 two-step cycles of 94°C for 30 sec and 55°C for 30 sec, and lastly at 68°C a single extension cycle for 1 min. Analysis of the PCR products was done by the GeXP machine (Beckman Coulter) which was loaded with a 96-well sample plate containing a mixture of PCR products (1 µl), sample loading solution (38.5 µl), and 0.5 µl DNA size standard 400 (GenomeLab™ GeXP Start Kit; Beckman Coulter). Fragment Analysis module of the GeXP system software was used to analyze the results and subsequently eXpress Profiler software was used for normalization.
Table 2.
Gene description | Accession no. | Primer sequence (with universal tags) |
---|---|---|
IPF1 | NM_022852 | F: AGGTGACACTATAGAATAACATCTCCCCATACGAAG |
R: GTACGACTCACTATAGGGAAAATAAGAATTCCTTCTCCAG | ||
B2ma,b | NM_012512 | F: AGGTGACACTATAGAATAATGCTTGCAGAGTTAAACA |
R: GTACGACTCACTATAGGGATGCATAAAATATTTAAGGTAAGA | ||
Actba | NM_031144 | F: AGGTGACACTATAGAATAAACTACATTCAATTCCATCA |
R: GTACGACTCACTATAGGGATAAAACGCAGCTCAGTAAC | ||
GLUT2 | NM_012879 | F: AGGTGACACTATAGAATACAGTACATTGCGGACTTC |
R: GTACGACTCACTATAGGGAGACTTTCCTTTGGTTTCTG | ||
Hprt1a | NM_012583 | F: AGGTGACACTATAGAATATCCTCATGGACTGATTATG |
R: GTACGACTCACTATAGGGACTGGTCATTACAGTAGCTCTT | ||
KanRc |
IPF1: insulin promoter factor 1; B2m: beta-2-microglobulin; Actb: beta actin; GLUT2: glucose transporter 2; Hprt1: Hypoxanthine-guanine phosphoribosyltransferase; KanR: kanamycin resistant.
Housekeeping genes
Normalization gene
Internal control.
Methylated DNA quantification
Methylated DNA was quantified using a fluorometric kit according to the manufacturers’ instructions. Absorbance was read on a microplate reader at the recommended wavelength and the result expressed as fold change with respect to the HFD result.
Total histone extraction
Extraction of total histone was done according to the manufacturer's instructions. Quantification of protein was calculated using bovine serum albumin (BSA) as standard curve (y=2.3639−0.0234, R2=0.9981).
Total histone H3 and H4 acetylation
Total Histone H3 and H4 Acetylation were performed according to the manufacturers’ instructions. Absorbance were read on a microplate reader at the recommended wavelength and the respective standard curves calculated (y=8.0054x+411.8, R2=0.9618 and y=835.06x+407.6, R2=0.9978, respectively). The amount of acetyl histone H3 and H4 were then determined by the formula below:
*Histone extract amount added into the sample well
Statistical analysis
Data were expressed as mean±standard deviation, and the means were compared using ANOVA (analysis of variance) with Tukey's multiple comparison test. Values for P<0.05 were considered statistically significant.
Results
Body weight
There were progressive increases in the body weights of the offspring across all groups (Fig. 1). The offspring in the HFD group had the highest weight gain among all groups, whereas those of the 50% GBR group had the lowest weight gain throughout their 8-week postnatal observation and had significantly lower weights at 8 weeks (p<0.05) in comparison with the HFD group. The offspring of the GELD and GEHD groups had comparatively similar weight gains throughout the observation period.
Oral glucose tolerance test
After administration of glucose load in the mothers, blood glucose levels of all the groups, except N, peaked at 30 min (Fig. 2a). Significant differences (p<0.05) were observed at 0, 60, and 120 min between HFD and the other groups. At 120 min, the HFD group had the highest blood glucose concentration of 9.60±0.57 mmol/l. No significant differences were observed between GBR, GEHD, and GELD groups at 120 min. In offspring, blood glucose levels of all the groups except HFD, peaked at 30 min. At 90 and 120 min significant differences (p<0.05) were observed between HFD and the other groups (Fig. 2b).
Insulin
Fasting serum insulin levels in the mothers were significantly lower (p<0.05) in the GBR group in comparison with the HFD group (Fig. 2c). In offspring (Fig. 2d), fasting serum insulin was significantly higher (p<0.05) in the HFD group in comparison with the other groups except GELD.
Homeostasis model assessment of insulin resistance (HOMA-IR)
The results of HOMA-IR were similar in the mothers (Fig. 2e) and offspring (Fig. 2f). The HFD groups of both mothers and offspring were significantly higher (p<0.05) compared with the other groups, which were not significantly different.
Adiponectin
At the end of the intervention, serum adiponectin levels were lowest in the HFD group in the mothers (Fig. 3a), whereas the other groups had significantly higher levels (p<0.05). Similarly, the offspring of the HFD group (Fig. 3b) had significantly lower levels in comparison with the other groups, except the GELD group, which was not significantly different.
Leptin
Serum leptin levels did not differ as much as the other markers. In mothers, the treatment groups had significantly lower levels (p<0.05) (Fig. 3c) in comparison with the HFD group. In the offspring (Fig. 3d), a similar pattern was observed in GBR and GEHD.
Retinol binding protein 4 (RBP4)
Serum RBP4 level was highest in the HFD group, whereas the N group had the lowest level in comparison to the other groups in the mothers (Fig. 3e). In the offspring, a similar pattern was observed although the N, GBR, and GEHD groups had similar levels (Fig. 3f).
Interleukin 6 (IL-6)
In mothers (Fig. 4a), serum IL-6 levels were significantly low in GBR and GEHD groups compared to HFD and N and this similarly was observed only in GBR offspring (Fig. 4b).
8 – Iso prostaglandin
The 8-isoPG levels in the mothers and offspring had similar patterns, with the HFD groups having the highest levels (p<0.05) in comparison with the other groups (Fig. 4c and d).
Hepatic mRNA levels
The expression of the Insulin Promoter Factor-1 gene was lowest in the HFD group in comparison with the other groups in mothers (Fig. 5a). In offspring, the HFD group showed similar results to those of the N, GELD, and GEHD groups (Fig. 5b), whereas the GBR group had the highest level. Hepatic GLUT2 expression was lowest in the HFD and GELD groups in the mothers (Fig. 5c), and a similar pattern was seen with the offspring, although in the GELD group it was significantly upregulated compared with the HFD group (Fig. 5d).
Methylated DNA quantification
DNA methylation was expressed in fold change with respect to the N group in both mothers and offspring. In the mothers, the level of DNA methylation was about twofold higher in the HFD and GELD groups compared with the N group, whereas the GBR and GEHD groups had lower levels than in the HFD group (Fig. 6a). Also, in the offspring, the GBR and GEHD groups had significantly lower (p<0.05) levels of methylated DNA (Fig. 6b).
Total histone H3 acetylation
Total histone H3 acetylation (ng/mg protein) levels in the mothers were elevated in the GBR and GELD groups in comparison with the HFD group (Fig. 6c). Acetylation levels were significantly higher in treatment groups in comparison with the HFD groups in the offspring except in the GEHD group (Fig. 6d).
Total histone H4 acetylation
The H4 acetylation patterns were different from those of the H3. The HFD group had significantly higher (p<0.05) levels in comparison with the other groups in the mothers (Fig. 6e), whereas no significant difference was observed when the HFD group is compared with the other treated groups in offspring (Fig. 6f).
Discussion
A significant number of adults are expected to be overweight and obese by the year 2030 (18). In view of the current global crisis, recent evidence of the complex gene–environment interaction is being closely evaluated as a potential therapeutic avenue for controlling the burden of this pandemic. As can be recalled, adverse prenatal and early postnatal environments influence the risk of developing insulin resistance, type 2 diabetes, and obesity later in life (3, 4). In this study, the body weight changes observed in the offspring in the different groups can be attributed to the different diets they were exposed to in utero because they consumed similar amounts of the same regular rat chow after weaning. Previous studies have shown that exposure to HFD in utero increases the risk of obesity in offspring (19) similar to our findings. Additionally, we have demonstrated that GBR attenuated weight gain in HFD-fed rats (16), which is similar to what was observed for the mothers in this study. This led to weight regulation in the offspring, and the multiple bioactive compounds in GBR are thought to contribute to this effect as shown by the superior effect of GBR over its GABA-rich extract. Furthermore, we have demonstrated that higher amounts of bioactive compounds in GBR contribute to its superior effects when compared to brown rice (13). The weight regulation by GBR was also expected because we have shown recently that brown rice was able to regulate weights of offspring when their mothers consumed a brown rice diet during pregnancy (14). Insulin sensitivity was assessed by HOMA-IR index. The significantly higher index of insulin resistance HOMA-IR in HFD groups of mothers and offspring demonstrates susceptibility toward an insulin-resistant state, which is associated with the intake of high-fat diets. In contrast, the consumption of GBR and GABA in mothers and by indirect exposure during pregnancy and lactation in offspring allowed for a better glycemic control as seen in lower fasting glucose and insulin levels consequently leading to lower HOMA-IR values.
Furthermore, the development of insulin resistance is closely linked with inflammation and alterations in the secretion of adipocytokines (20). Accordingly, the degree of adiposity has been shown to influence serum leptin adiponectin and IL-6 levels (21). Leptin, by controlling the size of the adipose tissue, regulates weight gain (22), whereas adiponectin enhances metabolism through various mechanisms (23). IL-6 is one of the most studied inflammatory cytokine, which modulates insulin resistance via numerous mechanisms such as the c-Jun N-terminal kinase 1 (JNK1)-mediated serine phosphorylation of IRS1, with elevated circulating IL-6 levels observed in insulin-resistant subjects (20). In this study, GBR and GABA improved serum leptin, adiponectin, and IL-6 levels toward better metabolic outcomes. Also, RBP4 is an important link between obesity and insulin resistance (24). There is an established relationship between serum RBP4 levels and increased risk of metabolic syndrome of which obesity, dyslipidemia, hyperglycemia, and insulin resistance are a part (25). Similarly, oxidative stress plays a vital role in numerous metabolic abnormalities observed in metabolic syndrome and tends to correlate with RBP4 levels (26). In the present study, HFD-induced metabolic abnormalities in mothers and offspring included elevation of RBP4 and oxidative stress (8-isoPG), which were attenuated by GBR and GABA.
GLUT2 expression is inversely influenced by HFD (27), in keeping with the present findings. The elevated levels of GLUT2 expression in the GBR groups are suggestive of enhanced glucose uptake for storage or metabolism. Similarly, IPF1 downregulation is observed in chronic dyslipidemia and hyperglycemia leading to β cell dysfuction (28). Upregulation of this gene was observed in the GBR and GEHD mothers as well as the GBR offspring. The offspring may have benefited from these effects through intrauterine reprogramming events that tended toward enhanced glucose homeostasis. We therefore hypothesized that epigenetic modifications underlined the effects of the perinatal dietary interventions seen in the offspring. As can be recalled, an adverse intrauterine environment as a result of nutritional imbalances is capable of interrupting the structural and functional programming required in fetal development (5, 6). These are often mediated through epigenetic modification of the genome occurring via DNA methylation or histone modification (4). DNA methylation is essential for normal development and can suppress or activate gene function (29). The most commonly studied histone modifications are those occurring on the lysine residues of H3 and H4 amino termini (30), which have revealed that transcriptional activation of gene is enhanced with increased acetylation (31). In this study, hepatic global DNA methylation, and global acetylation of H3 and H4 histones in the HFD groups were in favor of increased insulin resistance, whereas the GBR and GABA groups produced changes that tended toward improved insulin sensitivity. Multiple factors may have contributed to the epigenetic regulation of the risk of HFD-induced insulin resistance by GBR and GABA, including the potent antioxidative properties of GBR and its constituents (14). Furthermore, oxidative stress can lead to increased DNA methylation with consequent increase in the risk of insulin resistance (32), and attenuation of oxidative stress as seen in this study can lower such risks.
Taken together, the present data showed that GBR enhances metabolic outcomes in HFD-fed rats in keeping with enhanced insulin sensitivity. The data also showed that GBR-derived GABA-rich extract produced some favorable effects (increased adiponectin and reduced leptin, oxidative stress, and RBP4 levels in mothers and offspring). These differential effects may have been because of the multiple bioactive compounds in GBR. The epigenetic effects produced by GBR may have influenced transcriptional regulation of some genes involved in glucose homeostasis in the offspring, which could have been the basis for the changes seen in the GBR offspring. Studies have suggested in the past that nutritional intake does influence the degree of epigenetic modifications (5, 6), and in the present study we showed that GBR exposure during intrauterine development lowers global DNA methylation levels and modulates H3 and H4 acetylation status.
Conclusions
In the present study, we demonstrated that intrauterine exposure to GBR will influence metabolic outcomes in offspring of HFD-fed rats with underlying epigenetic changes and transcriptional implications that tend toward improved glucose homeostasis. GBR-derived GABA-rich extract also produced favorable metabolic outcomes although not as much as those of GBR. The presence of multiple bioactive compounds in GBR may underlie the superior effects of GBR over its GABA-rich extract. The translational implications of these findings are that consumption of GBR by pregnant women could modulate the risk of insulin resistance and other metabolic perturbations in their offspring even in the presence of environmental factors that promote risk of such diseases through epigenetic modifications. These findings are worth studying further.
Acknowledgements
This study was supported by grants from PadiBeras Nasional Berhad and Universiti Putra Malaysia (vote no 63536). The authors thank the staff of the Laboratory of Molecular Biomedicine for their assistance with this study.
Conflict of interest and funding
The authors declare there is no conflict of interest in submission of this paper to this journal.
References
- 1.Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3–21. doi: 10.1111/j.1753-4887.2011.00456.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Leonard WR. The global diversity of eating patterns: Human nutritional health in comparative perspective. PhysiolBehav. 2014;134(0):5–14. doi: 10.1016/j.physbeh.2014.02.050. [DOI] [PubMed] [Google Scholar]
- 3.Bruce K. Maternal and in utero determinants of type 2 diabetes risk in the young. Curr Diab Rep. 2013;14(1):1–8. doi: 10.1007/s11892-013-0446-0. [DOI] [PubMed] [Google Scholar]
- 4.Seki Y, Williams L, Vuguin PM, Charron MJ. Minireview: epigenetic programming of diabetes and obesity: animal models. Endocrinology. 2012;153(3):1031–8. doi: 10.1210/en.2011-1805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Guilloteau P, Zabielski R, Hammon H, Metges C. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol. 2009;60(Suppl 3):17–35. [PubMed] [Google Scholar]
- 6.Duque-Guimarães DE, Ozanne SE. Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol Metab. 2013;24(10):525–35. doi: 10.1016/j.tem.2013.05.006. [DOI] [PubMed] [Google Scholar]
- 7.Aguiree F, Brown A, Cho NH, Dahlquist G, Dodd S, Dunning T, et al. International diabetes federation diabetes atlas. 6th ed. Brussels: International Diabetes Federation; 2013. pp. 29–49. [Google Scholar]
- 8.Garber A, Abrahamson M, Barzilay J, Blonde L, Bloomgarden Z, Bush M, et al. AACE comprehensive diabetes management algorithm 2013. Endocrine Practice. 2013;19(2):327–36. doi: 10.4158/endp.19.2.a38267720403k242. [DOI] [PubMed] [Google Scholar]
- 9.Schuster D, Laggner C, Langer T. Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des. 2005;11(27):3545–59. doi: 10.2174/138161205774414510. [DOI] [PubMed] [Google Scholar]
- 10.Topping D. Cereal complex carbohydrates and their contribution to human health. J Cereal Sci. 2007;46(3):220–9. [Google Scholar]
- 11.Wu F, Yang N, Touré A, Jin Z, Xu X. Germinated brown rice and its role in human health. Crit Rev Food Sci Nutr. 2012;53(5):451–63. doi: 10.1080/10408398.2010.542259. [DOI] [PubMed] [Google Scholar]
- 12.Imam MU, Azmi NH, Bhanger MI, Ismail N, Ismail M. Antidiabetic properties of germinated brown rice: a systematic review. Evid Based Complement Alternat Med. 2012;2012:816501. doi: 10.1155/2012/816501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Imam MU, Ismail M. An overview on germinated brown rice and its nutragenomic implications. In: Bagchi D, Lau F, Bagchi M, editors. Genomics, proteomics and metabolomics in nutraceuticals and functional foods. New York: Wiley; 2015. pp. 504–17. [Google Scholar]
- 14.Imam MU, Ismail M, Ooi DJ, Sarega N, Ishaka A. Increased risk of insulin resistance in rat offspring exposed prenatally to white rice. Mol Nutr Food Res. 2015;59(1):180–4. doi: 10.1002/mnfr.201400396. [DOI] [PubMed] [Google Scholar]
- 15.Zamri NDM, Imam MU, Ghafar SAA, Ismail M. Antioxidative effects of germinated brown rice-derived extracts on H2O2-induced oxidative stress in HepG2 cells. Evid Based Complement Alternat Med. 2014;2014:371907. doi: 10.1155/2014/371907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Imam MU, Ishaka A, Ooi D-J, Zamri NDM, Sarega N, Ismail M, et al. Germinated brown rice regulates hepatic cholesterol metabolism and cardiovascular disease risk in hypercholesterolaemic rats. J Funct Foods. 2014;8:193–203. [Google Scholar]
- 17.Cacho J, Sevillano J, de Castro J, Herrera E, Ramos M. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab. 2008;295(5):E1269–76. doi: 10.1152/ajpendo.90207.2008. [DOI] [PubMed] [Google Scholar]
- 18.Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431–7. doi: 10.1038/ijo.2008.102. [DOI] [PubMed] [Google Scholar]
- 19.Masuyama H, Hiramatsu Y. Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology. 2012;153(6):2823–30. doi: 10.1210/en.2011-2161. [DOI] [PubMed] [Google Scholar]
- 20.Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14(11–12):741. doi: 10.2119/2008-00058.Rabe. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hadžović-Džuvo A, Lepara O, Valjevac A, Avdagić N, Začiragić A. Impact of high-fat diet on serum adiponectin and leptin level in streptozotocin-induced diabetes mellitus type 2. Folia Medica Facultatis Medicinae Universitatis Saraeviensis. 2014;49(2):110–5. [Google Scholar]
- 22.Baskin DG. Leptin interaction with brain orexigenic and anorexigenic pathways. Leptin: Springer; 2015. pp. 25–37. [Google Scholar]
- 23.Lihn A, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. 2005;6(1):13–21. doi: 10.1111/j.1467-789X.2005.00159.x. [DOI] [PubMed] [Google Scholar]
- 24.Rhie YJ, Choi B-M, Eun SH, Son CS, Park SH, Lee K-H. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci. 2011;26(6):797–802. doi: 10.3346/jkms.2011.26.6.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Conroy R, Espinal Y, Fennoy I, Accacha S, Boucher-Berry C, Carey DE, et al. Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab. 2011;24(11–12):913–19. doi: 10.1515/jpem.2011.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liu Y, Wang D, Li D, Sun R, Xia M. Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population. Diabetol Metab Syndr. 2014;6:25. doi: 10.1186/1758-5996-6-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Thorens B. Of fat, β cells, and diabetes. Cell Metab. 2011;14(4):439–40. doi: 10.1016/j.cmet.2011.09.006. [DOI] [PubMed] [Google Scholar]
- 28.Fujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic β-cell survival. Diabetes Obes Metab. 2009;11(s4):30–7. doi: 10.1111/j.1463-1326.2009.01121.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sterns JD, Smith CB, Steele JR, Stevenson KL, Gallicano GI. Epigenetics and type II diabetes mellitus: underlying mechanisms of prenatal predisposition. Front Cell Dev Biol. 2014;2:15. doi: 10.3389/fcell.2014.00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hyland EM, Cosgrove MS, Molina H, Wang D, Pandey A, Cottee RJ, et al. Insights into the role of histone H3 and histone H4 core modifiable residues in Saccharomyces cerevisiae . Mol Cell Biol. 2005;25(22):10060–70. doi: 10.1128/MCB.25.22.10060-10070.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Pinney SE, Simmons RA. Epigenetic mechanisms in the development of type 2 diabetes. Trends Endocrinol Metab. 2010;21(4):223–9. doi: 10.1016/j.tem.2009.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Pinney SE, Simmons RA. Metabolic programming, epigenetics, and gestational diabetes mellitus. Curr Diab Rep. 2012;12(1):67–74. doi: 10.1007/s11892-011-0248-1. [DOI] [PubMed] [Google Scholar]